Search by Drug Name or NDC
NDC 60505-0589-01 Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 2; 5 mg/mL; mg/mL Details
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 2; 5 mg/mL; mg/mL
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution is a OPHTHALMIC SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is BRIMONIDINE TARTRATE; TIMOLOL MALEATE.
MedlinePlus Drug Summary
Ophthalmic brimonidine is used to lower pressure in the eyes in patients who have glaucoma (high pressure in the eyes that may damage nerves and cause vision loss) and ocular hypertension (pressure in the eyes that is higher than normal but not high enough to cause vision loss). Brimonidine is in a class of drugs called alpha adrenergic agonists. Brimonidine works by decreasing the amount of fluid in the eyes.
Related Packages: 60505-0589-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Brimonidine Ophthalmic
Ophthalmic timolol is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision. Timolol is in a class of medications called beta-blockers. It works by decreasing the pressure in the eye.
Related Packages: 60505-0589-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Timolol Ophthalmic
Product Information
| NDC | 60505-0589 |
|---|---|
| Product ID | 60505-0589_163f1094-1376-46fa-05fc-b979a9998bb1 |
| Associated GPIs | |
| GCN Sequence Number | 053407 |
| GCN Sequence Number Description | brimonidine tartrate/timolol DROPS 0.2%-0.5% OPHTHALMIC |
| HIC3 | Q6G |
| HIC3 Description | MIOTICS AND OTHER INTRAOCULAR PRESSURE REDUCERS |
| GCN | 20876 |
| HICL Sequence Number | 025804 |
| HICL Sequence Number Description | BRIMONIDINE TARTRATE/TIMOLOL MALEATE |
| Brand/Generic | Generic |
| Proprietary Name | Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Brimonidine Tartrate and Timolol Maleate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 2; 5 |
| Active Ingredient Units | mg/mL; mg/mL |
| Substance Name | BRIMONIDINE TARTRATE; TIMOLOL MALEATE |
| Labeler Name | Apotex Corp. |
| Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Antagonists [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA091442 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 60505-0589-01 (60505058901)
| NDC Package Code | 60505-0589-1 |
|---|---|
| Billing NDC | 60505058901 |
| Package | 1 BOTTLE, DROPPER in 1 CARTON (60505-0589-1) / 5 mL in 1 BOTTLE, DROPPER |
| Marketing Start Date | 2022-10-19 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 15.1901 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | BRIMONIDINE-TIMOLOL 0.2%-0.5% |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |